Biodegradation of Doxylamine From Wastewater by a Green Microalga, Scenedesmus obliquus

Algae-Mediated Removal of Prevalent Genotoxic Antibiotics: Molecular Perspective on Algae-Bacteria Consortia and Bioreactor-Based Strategies

Antibiotic pollution poses a potential risk of genotoxicity, as antibiotics released into the environment can induce DNA damage and mutagenesis in various organisms. This pollution, stemming from pharmaceutical manufacturing, agriculture, and improper disposal, can disrupt aquatic ecosystems and potentially impact human health through the consumption of contaminated water and food. The removal of genotoxic antibiotics using algae-mediated approaches has gained considerable attention due to its potential for mitigating the environmental and health risks associated with these compounds. The paper provides an in-depth examination of the molecular aspects concerning algae and bioreactor-driven methodologies utilized for the elimination of deleterious antibiotics. The molecular analysis encompasses diverse facets, encompassing the discernment and profiling of algae species proficient in antibiotic degradation, the explication of enzymatic degradation pathways, and the refinement of bioreactor configurations to augment removal efficacy. Emphasizing the significance of investigating algal approaches for mitigating antibiotic pollution, this paper underscores their potential as a sustainable solution, safeguarding both the environment and human health.

Exploring eco-friendly approaches for mitigating pharmaceutical and personal care products in aquatic ecosystems: A sustainability assessment

Global water scarcity is exacerbated by climate change, population growth, and water pollution. Over half of the world's population will be affected by water shortages for at least a month annually by 2050 due toa lack of clean water sources. Even though recycling wastewater helps meet the growing demand, new pollutants, including pharmaceuticals and personal care products (PPCPs), pose a health threat since conventional methods cannot remove them and their environmental monitoring regulations are yet in place. Therefore, the current review aims to investigate and propose eco-friendly technologies for removing PPCPs from wastewater and their implementation strategies for ecosystem safety. Findings indicated the absence of a single wastewater treatment technology that can remove all PPCPs in a single operation. Instead, biotechnological methods are one of the alternatives that can remove PPCPs from aquatic environments. In this context, community involvement and knowledge transfer are identified keys to clean water resources' long-term sustainability.

Removal mechanisms of erythromycin by microalgae Chlorella pyrenoidosa and toxicity assessment during the treatment process

Microalgae-based biotechnology for antibiotic removal has received increasing attention as an economical and green method. This study investigated the removal mechanism of erythromycin by Chlorella pyrenoidosa and its correlation with the ecotoxic responses of microalgae. The degradation products (DPs) were identified, and their toxicity was predicted. The results indicated that only 4.04 %, 6.28 % and 23.53 % of erythromycin were left after 21-day microalgae treatment in 0.1, 1.0 and 10 mg/L treatments, respectively. Biodegradation contributed 48.62-67.01 %, 16.67-52.32 % and 6.42-24.82 %, while abiotic degradation contributed 8.76-29.61 %, 5.19-41.39 %, and 16.55-51.22 % to erythromycin attenuation in 0.1, 1.0, and 10 mg/L treatments, respectively. The growth and physiological-biochemical parameters of microalgae were slightly affected in low concentration treatment, which may be the main reason that biodegradation was the prominent removal mechanism. By contrast, oxidative damage in high concentration treatment inhibited the cell growth and chlorophyll content of microalgae, which hindered erythromycin biodegradation. In addition, eleven erythromycin degradation products (DPs) were identified during microalgae treatment of 21 days. Seven DPs including DP717, DP715, DP701A, DP701B, DP657, DP643, and DP557, represented higher toxicity to aquatic organisms than erythromycin.

Removal processes of individual and a mixture of organic micropollutants in the presence of Scenedesmus obliquus

Organic micropollutants (OMPs) need to be removed from wastewater as they can negatively affect aquatic organisms. It has been demonstrated that microalgae-based technologies are efficient in removing OMPs from wastewater. In this study, the removal processes and kinetics of six persistent OMPs (diclofenac, clarithromycin, benzotriazole, metoprolol, carbamazepine and mecoprop) were studied during cultivation of Scenedesmus obliquus in batch mode. These OMPs were added as individual compounds and in a mixture. Short experiments (8 days) were performed to avoid masking of OMP removal processes by light and nutrient limitation. The results show that diclofenac, clarithromycin, and benzotriazole were mainly removed by photodegradation (diclofenac), biodegradation (benzotriazole), or a combination of these two processes (clarithromycin). Peroxidase was involved in intracellular and extracellular biodegradation when benzotriazole was present as individual compound. Carbamazepine, metoprolol and mecoprop showed no biodegradation or photodegradation, and neglectable removal (<5%) by bioadsorption and bioaccumulation. Using an OMP mixture had an adverse effect on the photodegradation of clarithromycin and diclofenac, with reduced first-order kinetic constants compared to the individual compounds. Benzotriazole biodegradation was inhibited by the presence of the OMP mixture. This indicates that the presence of OMPs inhibits the photodegradation and biodegradation of some individual OMPs. These results will improve our understanding of removal processes of individual and mixtures of OMPs by microalgae-based technologies for wastewater treatment.

The potential of algae and aquatic macrophytes in the pharmaceutical and personal care products (PPCPs) environmental removal: a review

The presence of emerging contaminants, such as pharmaceuticals and personal care products (PPCPs), in aquatic environments has received increasing attention in the last years due to the various possible impacts on the dynamics of the natural environment and human health. In global terms, around 771 active pharmaceutical substances or their transformation products have been detected at levels above their respective detection limit. Additionally, 528 different compounds have been detected in 159 countries. Seeking to overcome potential ecotoxicological problems, several studies have been conducted using different technologies for PPCPs removal. Recently, the use of macro, microalgae, and aquatic macrophytes has been highlighted due to the excellent bioremediation capacity of these organisms and easy acclimatization. Thus, the present review aims to outline a brief and well-oriented scenario concerning the knowledge about the bioremediation alternatives of PPCPs through the use of macro, microalgae, and aquatic macrophytes. The characteristics of PPCPs and the risks of these compounds to the environment and human health are also addressed. Moreover, the review indicates the opportunities and challenges for expanding the use of biotechnologies based on algae and aquatic macrophytes, such as studies dedicated to relate the operational criteria of these biotechnologies with the main PPCPs removal mechanisms. Finally, algae and macrophytes can compose green and ecological biotechnologies for wastewater treatment, having great contribution to PPCPs removal.

Progress in microalgal mediated bioremediation systems for the removal of antibiotics and pharmaceuticals from wastewater

Worldwide demand for antibiotics and pharmaceutical products is continuously increasing for the control of disease and improvement of human health. Poor management and partial metabolism of these compounds result in the pollution of aquatic systems, leading to hazardous effects on flora, fauna, and ecosystems. In the past decade, the importance of microalgae in micropollutant removal has been widely reported. Microalgal systems are advantageous as their cultivation does not require additional nutrients: they can recover resources from wastewater and degrade antibiotics and pharmaceutical pollutants simultaneously. Bioadsorption, degradation, and accumulation are the main mechanisms involved in pollutant removal by microalgae. Integration of microalgae-mediated pollutant removal with other technologies, such as biodiesel, biochemical, and bioelectricity production, can make this technology more economical and efficient. This article summarizes the current scenario of antibiotic and pharmaceutical removal from wastewater using microalgae-mediated technologies.

Pharmaceuticals and personal care products in aquatic environments and their removal by algae-based systems

The consumption of pharmaceuticals and personal care products (PPCPs) has been widely increasing, yet up to 90-95% of PPCPs consumed by human are excreted unmetabolized. Moreover, the most of PPCPs cannot be fully removed by wastewater treatment plants (WWTPs), which release PPCPs to natural water bodies, affecting aquatic ecosystems and potentially humans. This study sought to review the occurrence of PPCPs in natural water bodies globally, and assess the effects of important factors on the fluxes of pollutants into receiving waterways. The highest ibuprofen concentration (3738 ng/L) in tap water was reported in Nigeria, and the highest naproxen concentration (37,700 ng/L) was reported in groundwater wells in Penn State, USA. Moreover, the PPCPs have affected aquatic organisms such as fish. For instance, up to 24.4 × 10³ ng/g of atenolol was detected in P. lineatus. Amongst different technologies to eliminate PPCPs, algae-based systems are environmentally friendly and effective because of the photosynthetic ability of algae to absorb CO₂ and their flexibility to grow in different wastewater. Up to 99% of triclosan and less than 10% of trimethoprim were removed by Nannochloris sp., green algae. Moreover, variable concentrations of PPCPs might adversely affect the growth and production of algae. The exposure of algae to high concentrations of PPCPs can reduce the content of chlorophyll and protein due to producing reactive oxygen species (ROS), and affecting expression of some genes in chlorophyll (rbcL, psbA, psaB and psbc).